IMPEDIMED LIMITED — Interim / Quarterly Report 2009

Feb 24, 2009

Appendix 4D Half Year Ending 31 December 2008

ImpediMed Ltd ABN 65 089 705 144

Appendix 4D

1 for the half year ended 31 December 2008 (previous corresponding period : half year ended 31 December 2007)

The information contained in this document should be read in conjunction with the ImpediMed Limited Half Year Report for the half year ended 31 December 2008 and any public announcements made by ImpediMed Limited and its controlled entities during the year in accordance with continuous disclosure obligations arising under the ASX Listing Rules.

==> picture [464 x 418] intentionally omitted <==

----- Start of picture text ----- 2 Results for announcement to the marketPreviousCurrentcorrespondingperiodperiod$ $2.1 Revenue from ordinary activities 1,567,549 1,165,615Increase / (decrease) in revenue: 401,934Percentage increase / (decrease): 34%2.2 Profit / (loss) from ordinary activities after tax attributable to members (7,750,091) (5,552,155)(Increase) / decrease in profit / (loss) from ordinary: activities after tax attributable to members (2,197,936)Percentage (increase) / decrease: (40%)2.3 Net profit / (loss) for the period attributable to members (7,750,091) (5,552,155)(Increase) / decrease in net profit / (loss) for the period attributable to members: (2,197,936)Percentage (increase) / decrease: (40%)2.4 Dividends NIL NILThere were no dividends declared and paid during the half year on ordinary shares.There were no dividends proposed and not yet recognised as a liability during the half year.2.5 Dividend Record Date Not applicable2.6 Explanation of operating performanceRefer to the Review and Results of Operations in the Directors' Report of the Financial Statements for thecurrent reporting period.----- End of picture text -----

Appendix 4D Half Year Ending 31 December 2008

3 Net tangible assets per ordinary security

Net tangible assets per ordinary security
	Currentperiod	Previouscorrespondingperiod
	$	$
Net tangible assets	5,824,921	13,330,431
Issued share capital at reporting date	54,949,342	50,404,234
	Currentperiod	Previouscorrespondingperiod
Number of shares on issue at reporting date	87,318,858	80,830,990
Net tangible assets per ordinary security	0.07	0.16

4 Acquisitions and divestments

4.1 There were no entities over which control has been gained or lost during the current reporting period.

4.2 Not applicable

4.3 Not applicable

5 Details of dividends

There were no dividends paid during the period, or payable at 31 December 2008.

6 Dividend Reinvestment Plans

The company has no dividend reinvestment plan.

7 Associates and joint ventures

There are no equity accounted associates and joint venture entities.

8 Accounting standards

The financial report for the group has been prepared in accordance with Australian Equivalents to International Financial Reporting Standards.

9 Auditors' review report

The review report prepared by the independent auditor Ernst & Young is not subject to any dispute or qualification, and is provided with the half year financial statements.